Literature DB >> 2153239

Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3.

M M Falk1, P R Grigera, I E Bergmann, A Zibert, G Multhaup, E Beck.   

Abstract

In foot-and-mouth disease virus (FMDV)-infected cells, the disappearance of nuclear protein histone H3 and the simultaneous appearance of a new chromatin-associated protein termed Pi can be observed (P. R. Grigera and S. G. Tisminetzky, Virology 136:10-19, 1984). We sequenced the amino terminus of protein Pi and showed that Pi derives from histone H3 by proteolytic cleavage. The 20 N-terminal amino acid residues of histone H3 are specifically cleaved off early during infection. Truncated histone H3 remains chromatin associated. In addition, we showed that the histone H3-Pi transition is catalyzed by the FMDV 3C protease. The only known function of the viral 3C protease was, until now, the processing of the viral polyprotein. The viral 3C protease is the only FMDV protein required to induce the histone H3-Pi transition, as well as being the only viral protein capable of cleaving histone H3. No viral precursor fusion protein is needed for this specific cleavage as was reported for the processing of the poliovirus P1 precursor polyprotein by 3C/D protease. As the deleted part of the histone H3 corresponds to the presumed regulatory domain involved in the regulation of transcriptionally active chromatin in eucaryotes, it seems possible that this specific cleavage of histone H3 is related to the host cell transcription shutoff reported for several picornaviruses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153239      PMCID: PMC249169     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Translation of encephalomyocarditis virus RNA in vitro yields an active proteolytic processing enzyme.

Authors:  H R Pelham
Journal:  Eur J Biochem       Date:  1978-04-17

2.  An octamer of histones in chromatin and free in solution.

Authors:  J O Thomas; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

3.  Altered nucleosomes of active nucleolar chromatin contain accessible histone H3 in its hyperacetylated forms.

Authors:  E M Johnson; R Sterner; V G Allfrey
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

4.  Differential acetylation of core histones in rat cerebral cortex neurons during development and aging.

Authors:  B Piña; P Martínez; P Suau
Journal:  Eur J Biochem       Date:  1988-06-01

5.  Characterization of the large picornaviral polypeptides produced in the presence of zinc ion.

Authors:  B E Butterworth; B D Korant
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

6.  Transcription of cloned Xenopus ribosomal genes visualised after injection into oocyte nuclei.

Authors:  M F Trendelenburg; J B Gurdon
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

Review 7.  Active chromatin.

Authors:  S Weisbrod
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

Review 8.  Transcriptionally active chromatin.

Authors:  R Reeves
Journal:  Biochim Biophys Acta       Date:  1984-09-10

9.  Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis.

Authors:  M W Hunkapiller; E Lujan; F Ostrander; L E Hood
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

10.  A novel yeast histone deacetylase: partial characterization and development of an activity assay.

Authors:  W R Alonso; D A Nelson
Journal:  Biochim Biophys Acta       Date:  1986-03-26
View more
  61 in total

1.  The highly conserved N-terminal domains of histones H3 and H4 are required for normal cell cycle progression.

Authors:  B A Morgan; B A Mittman; M M Smith
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

2.  Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells.

Authors:  G J Belsham; G M McInerney; N Ross-Smith
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.

Authors:  A H Kaplan; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

4.  Interaction of a cellular 57-kilodalton protein with the internal translation initiation site of foot-and-mouth disease virus.

Authors:  N Luz; E Beck
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 5.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

6.  Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro.

Authors:  P Yalamanchili; U Datta; A Dasgupta
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks.

Authors:  N Blom; J Hansen; D Blaas; S Brunak
Journal:  Protein Sci       Date:  1996-11       Impact factor: 6.725

8.  Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation.

Authors:  Elizabeth M Duncan; Tara L Muratore-Schroeder; Richard G Cook; Benjamin A Garcia; Jeffrey Shabanowitz; Donald F Hunt; C David Allis
Journal:  Cell       Date:  2008-10-17       Impact factor: 41.582

9.  Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores.

Authors:  George A Belov; Peter V Lidsky; Olga V Mikitas; Denise Egger; Konstantin A Lukyanov; Kurt Bienz; Vadim I Agol
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 10.  Viral and host proteins involved in picornavirus life cycle.

Authors:  Jing-Yi Lin; Tzu-Chun Chen; Kuo-Feng Weng; Shih-Cheng Chang; Li-Lien Chen; Shin-Ru Shih
Journal:  J Biomed Sci       Date:  2009-11-20       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.